Alan F. Denenberg

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by NuVasive, Inc. of $400 million aggregate principal amount of its 1.000%…

Davis Polk advised Penumbra, Inc. on its SEC-registered follow-on public offering of 865,963 shares of common stock for an aggregate price to the public of approximately $143.75 million,…

Davis Polk advised the joint book-running managers and representatives of the initial purchasers in connection with a Rule 144A offering by 1Life Healthcare, Inc. of $275 million…

Davis Polk advised the underwriters in connection with an SEC-registered offering by Applied Materials, Inc. of $750 million aggregate principal amount of its 1.750% notes due 2030 and $750…

Davis Polk acted as special product counsel to the representatives of the initial purchasers in connection with a Rule 144A offering by Five9, Inc. of an aggregate principal amount of …

Davis Polk advised the joint book-running managers in connection with the $460 million public offering of 5,000,000 shares of Class A common stock of Carvana Co. The Class A common…

Davis Polk advised the joint book-running managers in connection with a $325 million SEC-registered common stock offering by Turning Point Therapeutics, Inc. The common stock is listed…

Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering by Xilinx, Inc. of $750 million aggregate principal amount of its 2.375%…

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the SEC-registered offering of $1 billion aggregate principal amount of 1…

Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S offering by Uber Technologies, Inc. of $900 million aggregate principal amount of…